FI883592A - Foerfarande foer framstaellning av nya n-substituerade bensamider. - Google Patents

Foerfarande foer framstaellning av nya n-substituerade bensamider. Download PDF

Info

Publication number
FI883592A
FI883592A FI883592A FI883592A FI883592A FI 883592 A FI883592 A FI 883592A FI 883592 A FI883592 A FI 883592A FI 883592 A FI883592 A FI 883592A FI 883592 A FI883592 A FI 883592A
Authority
FI
Finland
Prior art keywords
bensamider
substituerade
nya
fuer
framstaellning
Prior art date
Application number
FI883592A
Other languages
English (en)
Finnish (fi)
Other versions
FI883592A0 (fi
Inventor
Noverola Armando Vega
Soto Jose Manuel Prieto
Noguera Fernando Pujol
Mauri Jacinto Moragues
Robert Geoffrey Willi Spickett
Original Assignee
Fordonal Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fordonal Sa filed Critical Fordonal Sa
Publication of FI883592A0 publication Critical patent/FI883592A0/fi
Publication of FI883592A publication Critical patent/FI883592A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI883592A 1987-08-03 1988-08-01 Foerfarande foer framstaellning av nya n-substituerade bensamider. FI883592A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878718345A GB8718345D0 (en) 1987-08-03 1987-08-03 N-substituted benzamides

Publications (2)

Publication Number Publication Date
FI883592A0 FI883592A0 (fi) 1988-08-01
FI883592A true FI883592A (fi) 1989-02-04

Family

ID=10621740

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883592A FI883592A (fi) 1987-08-03 1988-08-01 Foerfarande foer framstaellning av nya n-substituerade bensamider.

Country Status (22)

Country Link
US (2) US4877780A (da)
EP (1) EP0302699A3 (da)
JP (1) JPS6450883A (da)
KR (1) KR890003760A (da)
CN (1) CN1031701A (da)
AU (1) AU629175B2 (da)
CS (1) CS272794B2 (da)
DD (1) DD282010A5 (da)
DK (1) DK429988A (da)
FI (1) FI883592A (da)
GB (1) GB8718345D0 (da)
HU (1) HU200460B (da)
IL (1) IL87080A (da)
MX (1) MX12478A (da)
NO (1) NO168422C (da)
NZ (1) NZ225657A (da)
PH (1) PH25048A (da)
PL (1) PL154302B1 (da)
PT (1) PT88175A (da)
RO (1) RO101203B (da)
SU (1) SU1739849A3 (da)
ZA (1) ZA885418B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820715A (en) * 1984-06-28 1989-04-11 Bristol-Myers Company Anti-emetic quinuclidinyl benzamides
ATE82124T1 (de) * 1987-06-17 1992-11-15 Delagrange Lab Anwendung von n-(2-(diaethylamino)aethyl>-2-methoxy-4((1-h-4,5ihydro-2-imidazolyl)amino>-5- chlorobenzamid als anxiolytisches und antipsychotisches mittel.
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
FR2640507A1 (fr) * 1988-12-20 1990-06-22 Delagrange Laboratoires Application de benzamides substitues comme anxiolytiques et anti-psychotiques
IL100432A (en) * 1990-12-27 1996-01-19 Erba Carlo Spa Dihydrobenzopuran carboxamides, their preparation and pharmaceutical preparations containing them
US5395832A (en) * 1991-02-15 1995-03-07 Hokuriku Seiyaku Co., Ltd. Benzamide derivatives
TW213460B (da) * 1991-02-15 1993-09-21 Hokuriku Pharmaceutical
DE69319939T2 (de) * 1992-02-04 1999-02-18 Eisai Co., Ltd., Tokio/Tokyo Aminobenzoesäure Derivate
US5236931A (en) * 1992-03-26 1993-08-17 A. H. Robins Company, Incorporated 2-substituted benzamide and benzoate derivatives of 3-aminoquinuclidine and 3-quinuclidinol
US5864039A (en) * 1994-03-30 1999-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and use thereof as medicaments
US5723103A (en) * 1994-12-09 1998-03-03 Vanderbilt University Substituted benzamides and radioligand analogs and methods of use
US6083991A (en) 1997-06-04 2000-07-04 University Of Florida Research Foundation, Inc. Anti-arrhythmic composition and methods of treatment
AR022338A1 (es) 1999-02-04 2002-09-04 Hokuriku Pharmaceutical Un compuesto de benzamida, medicamento que lo contiene, y uso para la manufactura de un medicamento para el tratamiento o prevencion de una enfermedad digestiva o para mejorar la movilidad del tracto gastrointestinal.
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
WO2002016357A2 (en) 2000-08-18 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
AU2001282874A1 (en) 2000-08-18 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
KR100381886B1 (ko) * 2001-03-21 2003-04-26 유니모씨엔티 주식회사 무선통신용 중계기의 씨디엠에이 신호 검출장치
PE20021019A1 (es) 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
MXPA04000779A (es) * 2001-08-24 2004-04-20 Pharmacia & Up John Company 7-aza[2.2.1]bicicloheptanos sustituidos con arilo para el tratamiento de enfermedades.
MXPA04007936A (es) 2002-02-15 2004-11-26 Upjohn Co Compuestos de aril-sustituidos para el tratamiento de enfermedades.
MXPA04007083A (es) * 2002-02-20 2004-10-29 Upjohn Co Compuestos azabiciclicos para el tratamiento de enfermedades.
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
ES2432618T3 (es) 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular
JP5955767B2 (ja) 2009-05-20 2016-07-20 インセルム（インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル） 損傷性前庭障害の処置における使用のためのセロトニン５−ｈｔ３受容体拮抗薬
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
US9692588B2 (en) 2015-07-07 2017-06-27 Samsung Electronics Co., Ltd. System and method for performing synchronization and interference rejection in super regenerative receiver (SRR)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068700A1 (en) * 1981-06-29 1983-01-05 Beecham Group Plc Azobicycloalkylbenzamides, process for their preparation and pharmaceutical compositions containing them
FR2529548A1 (fr) * 1982-07-02 1984-01-06 Delalande Sa Nouveaux derives de l'amino-3 quinuclidine, leur procede et leur application en therapeutique
EP0099194A3 (en) * 1982-07-03 1984-04-11 Beecham Group Plc Novel benzamides
EP0102195A3 (en) * 1982-08-03 1984-04-11 Beecham Group Plc Substituted aza bicycloalkyl derivatives with dopamine antagonist activity
US4820715A (en) * 1984-06-28 1989-04-11 Bristol-Myers Company Anti-emetic quinuclidinyl benzamides
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides
US4870181A (en) * 1985-02-04 1989-09-26 A. H. Robins Company, Incorporated Process for the preparation of 2-alkoxy-N-(1-azabicyclo[2.2.2])octan-3-yl)aminobenzamides
EP0220011A3 (en) * 1985-10-12 1990-01-03 Beecham Group Plc Use of azabicloalkylbenzamides in the treatment of gastrointestinal motility disorders, migraine, emesis, cluster headaches, trigeminal neuralgia and arrhythmia
US4717563A (en) * 1986-03-05 1988-01-05 A. H. Robins Company, Inc. 2-alkoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides in a method for alleviating emesis caused by non-platinum anticancer drugs

Also Published As

Publication number Publication date
US4937236A (en) 1990-06-26
DK429988D0 (da) 1988-08-02
US4877780A (en) 1989-10-31
NO168422B (no) 1991-11-11
PT88175A (pt) 1989-06-30
PL274010A1 (en) 1989-10-16
EP0302699A3 (en) 1990-07-11
CN1031701A (zh) 1989-03-15
HUT48246A (en) 1989-05-29
IL87080A (en) 1992-09-06
NO883428L (no) 1989-02-06
ZA885418B (en) 1989-04-26
KR890003760A (ko) 1989-04-17
FI883592A0 (fi) 1988-08-01
IL87080A0 (en) 1988-12-30
HU200460B (en) 1990-06-28
PH25048A (en) 1991-01-28
EP0302699A2 (en) 1989-02-08
CS272794B2 (en) 1991-02-12
GB8718345D0 (en) 1987-09-09
DD282010A5 (de) 1990-08-29
NZ225657A (en) 1991-07-26
CS539788A2 (en) 1990-06-13
DK429988A (da) 1989-04-05
RO101203B (ro) 1992-01-10
MX12478A (es) 1993-12-01
NO883428D0 (no) 1988-08-02
AU629175B2 (en) 1992-10-01
AU2029388A (en) 1989-02-09
NO168422C (no) 1992-02-19
JPS6450883A (en) 1989-02-27
SU1739849A3 (ru) 1992-06-07
PL154302B1 (en) 1991-07-31

Similar Documents

Publication Publication Date Title
FI883592A0 (fi) Foerfarande foer framstaellning av nya n-substituerade bensamider.
FI881825A0 (fi) Framstaellning av nya heterobicykliska kinolonderivat.
FI880173A0 (fi) Nya peptidasinhibitorer.
FI881650A (fi) Foerfarande foer framstaellning av nya acylderivat.
FI880469A (fi) Nya polyaminderivat.
FI884305A (fi) Nya amidinotricyklderivat.
FI884627A (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara dideoxicytidinderivat.
FI881571A0 (fi) Nya ribofuransyraderivator.
FI881639A0 (fi) Foerfarande foer framstaellning av nya substituerade anilidderivat.
FI884304A0 (fi) Nya amidinoderivat.
FI882640A0 (fi) Nya heterocykliska pesticida foereningar.
FI881641A0 (fi) Foerfarande foer framstaellning av nya acylderivat.
FI884752A0 (fi) Foerfarande foer framstaellning av nya kinolinderivat.
FI883146A0 (fi) Nya foereningar.
FI884106A0 (fi) Foerfarande foer framstaellning av nya antibakteriella 4-oxo-3-kinolinkarboxylsyror.
FI871320A0 (fi) Nya langmuir-blodgettmembranstrukturer.
FI884535A (fi) Foerfarande foer framstaellning av nya kinolinium- och isokinoliniumderivat.
FI886065A (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara dioxazocinderivat.
FI881921A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara kinolintioetrar.
FI880536A (fi) Foerfarande foer framstaellning av nya 1-detia-2-tiakefalosporinderivat.
FI914338A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara kastanosperminglykosider.
FI885047A0 (fi) Framstaellningsfoerfarande av nya oktahydroindenofuranderivat.
FI875426A0 (fi) Foerfarande foer framstaellning av nya antibakteriella guanidinderivat av kinolonkarboxylsyror.
FI913098A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara tricykliska triatsolpyrimidinderivat.
FI871462A0 (fi) Nya mineralprodukter.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: WALTON S.A.